Avivomed
Roseville, US · Founded 2021 · Delaware corporation · 4 known investors
Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea. Based in the Minneapolis area, it targets mild-to-moderate OSA patients who cannot tolerate CPAP.
BiotechDeep TechHealthtechMedical Devices
Founders & leadership
PM
Paul MazanecChief Executive Officer
TC
Theresa C. PappasDirector
KP
Ketan PatelDirector
CD
Casper de ClercqDirector
DR
Douglas ReedDirector
SM
Stephen MassonExecutive Officer, Director
LE
Lynn ElliottCo-Founder
MJ
Mudit JainCo-Founder
MK
Mudit K. JainDirector
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$5MraisedApr 2026 · 7 investors · BiotechnologyRule 506(b)
▶$5MraisedApr 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul MazanecExecutive Officer, Director
- Theresa C. PappasDirector
- Ketan PatelDirector
- Casper de ClercqDirector
- Douglas ReedDirector
- Mudit K. JainDirector
- Offering amount
- $12M
- Amount sold
- $5M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$20.1MraisedNov 2021 · 6 investors · BiotechnologyRule 506(b)
▶$20.1MraisedNov 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ketan PatelDirector
- Mudit K. JainDirector
- Stephen MassonExecutive Officer, Director
- Casper de ClercqDirector
- Theresa C. PappasDirector
- Douglas ReedDirector
- Offering amount
- $32M
- Amount sold
- $20.1M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Avivomed Inc. raises $5M; offering $12M: Form Dainvest.com · 2026
- Avivomed Raises $32M in Series A Financing - FinSMEsfinsmes.com · 2021
- Avivomed Raises $32 Million in Series A Financing - Dec 02, 2021 - BioSpacebiospace.com · 2021